APA (7th ed.) Citation

JW, W., DL, Y., SC, C., MJ, L., YR, L., XY, W., . . . P, C. (2026). Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008). Scientific reports. https://doi.org/10.1038/s41598-026-53344-3

Chicago Style (17th ed.) Citation

JW, Wu, et al. "Progression-free Survival as a Potential Surrogate Endpoint for Overall Survival After Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE008)." Scientific Reports 2026. https://doi.org/10.1038/s41598-026-53344-3.

MLA (9th ed.) Citation

JW, Wu, et al. "Progression-free Survival as a Potential Surrogate Endpoint for Overall Survival After Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE008)." Scientific Reports, 2026, https://doi.org/10.1038/s41598-026-53344-3.